During the past decade, City Clinical Hospital #10 conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "City Clinical Hospital #10" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "City Clinical Hospital #10" are "Severe Hypertriglyceridemia" (2 trials), "Ulcerative Colitis" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "City Clinical Hospital #10" in a lesser frequency.

Most popular intervention types in "City Clinical Hospital #10" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Etrasimod" (3 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "City Clinical Hospital #10" are 5 trials for "All" genders.

Currently, there are NaN active trials in "City Clinical Hospital #10". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in City Clinical Hospital #10, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in City Clinical Hospital #10, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".